Literature DB >> 23835489

Extraintestinal manifestations and complications in IBD.

Claudia Ott1, Jürgen Schölmerich.   

Abstract

More than one-third of patients with IBD are affected by extraintestinal manifestations or extraintestinal complications beyond the intestinal manifestation of the disease. The most common manifestations include arthropathies, mucocutaneous and ophthalmological manifestations, as well as conditions affecting the hepatobiliary system, both in Crohn's disease and ulcerative colitis. However, less frequent manifestations, such as pulmonary or neurological manifestations, should also be considered in patients with IBD. Several extraintestinal manifestations follow the course of the underlying intestinal activity, whereas others are independent from the intestinal inflammation. Extraintestinal complications such as iron-deficiency anaemia and osteoporosis are consequences of the intestinal disease or of disease-specific treatment. As extraintestinal manifestations and complications strongly influence quality of life, and to avoid severe complications, adequate treatment is mandatory in affected patients. We provide a comprehensive overview of different extraintestinal manifestations and complications, including their management, in patients with IBD.

Entities:  

Mesh:

Year:  2013        PMID: 23835489     DOI: 10.1038/nrgastro.2013.117

Source DB:  PubMed          Journal:  Nat Rev Gastroenterol Hepatol        ISSN: 1759-5045            Impact factor:   46.802


  124 in total

Review 1.  Extraintestinal manifestations in inflammatory bowel disease.

Authors:  Silvio Danese; Stefano Semeraro; Alfredo Papa; Italia Roberto; Franco Scaldaferri; Giuseppe Fedeli; Giovanni Gasbarrini; Antonio Gasbarrini
Journal:  World J Gastroenterol       Date:  2005-12-14       Impact factor: 5.742

2.  Hepatosplenic T cell lymphoma in inflammatory bowel disease.

Authors:  Matthew Shale; Ed Kanfer; Remo Panaccione; Subrata Ghosh
Journal:  Gut       Date:  2008-07-30       Impact factor: 23.059

Review 3.  The joint-gut axis in inflammatory bowel diseases.

Authors:  Lianne K P M Brakenhoff; Désirée M van der Heijde; Daniel W Hommes; Tom W J Huizinga; Herma H Fidder
Journal:  J Crohns Colitis       Date:  2009-11-30       Impact factor: 9.071

4.  Safety of selective cyclooxygenase-2 inhibitors in inflammatory bowel disease.

Authors:  Uma Mahadevan; Edward V Loftus; William J Tremaine; William J Sandborn
Journal:  Am J Gastroenterol       Date:  2002-04       Impact factor: 10.864

Review 5.  Progress in the genetics of ankylosing spondylitis.

Authors:  Matthew A Brown
Journal:  Brief Funct Genomics       Date:  2011-09-30       Impact factor: 4.241

6.  Clinical patterns of familial inflammatory bowel disease.

Authors:  J Satsangi; C Grootscholten; H Holt; D P Jewell
Journal:  Gut       Date:  1996-05       Impact factor: 23.059

7.  Spondyloarthropathy is underestimated in inflammatory bowel disease: prevalence and HLA association.

Authors:  K de Vlam; H Mielants; C Cuvelier; F De Keyser; E M Veys; M De Vos
Journal:  J Rheumatol       Date:  2000-12       Impact factor: 4.666

8.  Quality of life in chronic anemia of cancer during treatment with recombinant human erythropoietin.

Authors:  C Leitgeb; M Pecherstorfer; E Fritz; H Ludwig
Journal:  Cancer       Date:  1994-05-15       Impact factor: 6.860

9.  Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis. Glucocorticoid-Induced Osteoporosis Intervention Study Group.

Authors:  K G Saag; R Emkey; T J Schnitzer; J P Brown; F Hawkins; S Goemaere; G Thamsborg; U A Liberman; P D Delmas; M P Malice; M Czachur; A G Daifotis
Journal:  N Engl J Med       Date:  1998-07-30       Impact factor: 91.245

10.  Pyoderma gangrenosum associated with ulcerative colitis: response to infliximab.

Authors:  A López San Román; F Bermejo; I Aldanondo; E Carrera; D Boixeda; E Muñoz Zato
Journal:  Rev Esp Enferm Dig       Date:  2004-06       Impact factor: 2.086

View more
  82 in total

1.  Pulmonary Crohn's Disease.

Authors:  Kirsten Regalia; Andrew Shelton; Gerald Berry; George Triadafilopoulos; Christine A Cartwright
Journal:  Dig Dis Sci       Date:  2015-12-21       Impact factor: 3.199

2.  Prevalence and Characteristics of Extra-intestinal Manifestations in a Large Cohort of Greek Patients with Inflammatory Bowel Disease.

Authors:  Konstantinos Karmiris; Anastasios Avgerinos; Aikaterini Tavernaraki; Christos Zeglinas; Pantelis Karatzas; Theodoros Koukouratos; Konstantinos A Oikonomou; Athanasios Kostas; Evanthia Zampeli; Vasileios Papadopoulos; Angeliki Theodoropoulou; Nikos Viazis; Dimitrios Polymeros; Spyridon Michopoulos; Giorgos Bamias; Andreas Kapsoritakis; Dimitrios G Karamanolis; Gerassimos J Mantzaris; Charalampos Tzathas; Ioannis E Koutroubakis
Journal:  J Crohns Colitis       Date:  2015-12-30       Impact factor: 9.071

3.  Achilles tendinitis as a rare extraintestinal manifestation of ulcerative colitis.

Authors:  Takahiro Zenda; Ichiro Araki; Otoyuki Nakamiya; Yuji Tokuumi; Yuka Shimada; Keigo Komai; Yukie Taniuchi
Journal:  Clin J Gastroenterol       Date:  2016-04-08

Review 4.  Current management of iron deficiency anemia in inflammatory bowel diseases: a practical guide.

Authors:  Fernando Gomollón; Javier P Gisbert
Journal:  Drugs       Date:  2013-11       Impact factor: 9.546

5.  Smoking increases the risk of extraintestinal manifestations in Crohn's disease.

Authors:  Claudia Ott; Angela Takses; Florian Obermeier; Elisabeth Schnoy; Martina Müller
Journal:  World J Gastroenterol       Date:  2014-09-14       Impact factor: 5.742

Review 6.  Location is important: differentiation between ileal and colonic Crohn's disease.

Authors:  Raja Atreya; Britta Siegmund
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2021-03-12       Impact factor: 46.802

Review 7.  Ulcerative Colitis: Update on Medical Management.

Authors:  Heba N Iskandar; Tanvi Dhere; Francis A Farraye
Journal:  Curr Gastroenterol Rep       Date:  2015-11

Review 8.  Crohn's disease.

Authors:  Giulia Roda; Siew Chien Ng; Paulo Gustavo Kotze; Marjorie Argollo; Remo Panaccione; Antonino Spinelli; Arthur Kaser; Laurent Peyrin-Biroulet; Silvio Danese
Journal:  Nat Rev Dis Primers       Date:  2020-04-02       Impact factor: 52.329

9.  Symptomatic sensorineural hearing loss in patients with ulcerative colitis.

Authors:  G Casella; D Corbetta; M Zolezzi; C Di Bella; V Villanacci; M Salemme; U Milanesi; E Antonelli; V Baldini; G Bassotti
Journal:  Tech Coloproctol       Date:  2015-08-18       Impact factor: 3.781

Review 10.  Current clinical issue of skin lesions in patients with inflammatory bowel disease.

Authors:  Tomoya Iida; Tokimasa Hida; Minoru Matsuura; Hisashi Uhara; Hiroshi Nakase
Journal:  Clin J Gastroenterol       Date:  2019-03-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.